Azole compounds as ubiquitin-specific protease USP7 inhibitors
US11273154B2 · kind B2 · utility
0Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2018 |
| Grant date | Mar 15, 2022 |
| Priority date | — |
| Expiry date | Mar 2, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method and compounds for treating cancer by, for example, modulating immune system activity, are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.